Symbol: |
BRK1
|
Description: |
BRICK1, SCAR/WAVE actin-nucleating complex subunit [Source:HGNC Symbol;Acc:23057]
|
Location: |
Chr3:10157276-10168874[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:145
Gene |
Compound |
Gen_sig |
Exp_pattern |
BRK1 |
NSC 270927 |
0.037 |
Up |
BRK1 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.028 |
Down |
BRK1 |
2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- |
0.014 |
Up |
BRK1 |
7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-[(4-aminophenyl)methyl]-, dihydrochloride |
0.001 |
Up |
BRK1 |
AZETIDINE CARBOTHIOIC ACID, [1-(2-PYRIDINYL)ETHYLIDENE]HYDRAZIDE |
0.032 |
Up |
BRK1 |
NSC 328087 |
0.016 |
Down |
BRK1 |
VOBTUSINE, (3E)-HYDROXY- |
0.023 |
Down |
BRK1 |
9,10-o-Benzenoanthracene-1,4-dione, 2,3-dichloro-9,10-dihydro- |
0.015 |
Down |
BRK1 |
FCDR |
0.03 |
Up |
BRK1 |
NSC 49692 |
0.038 |
Down |
BRK1 |
Camptothecin ethylglycinate ester hydrochloride |
0.03 |
Up |
BRK1 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.01 |
Down |
BRK1 |
NSC 632780 |
0.034 |
Down |
BRK1 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.036 |
Down |
BRK1 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.001 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|